헤더 로고

• All Rooms
• Galaxy Theater & Discovery Hall
• Galaxy Theater
• Discovery Hall
• Universe Arena
• Supernova Stage

March 27 (Friday)

[SS08] Scientific Session 08: Microbiome-Driven Precision Medicine in Hematology Discovery Hall

• March 27 (Fri), 09:00-10:15
• TBD
• 09:00-09:25 Microbial Molecules as Emerging Biomarkers in Hematologic Diseases Christoph K. Stein-Thoeringer (University Clinic Tübingen, Germany) 09:25-09:50 Gut Microbiome as a Predictive Biomarker and Emerging Intervention Target in DLBCL Woorim Kang (Kangwon National University, Korea) 09:50-10:15 Microbiome in Allogeneic Hematopoietic Cell Transplantation & Immunotherapy Jonathan U. Peled (Memorial Sloan Kettering Cancer Center, USA)

[SS09] Scientific Session 09: Future of Immunotherapy in DLBCL Universe Arena

• March 27 (Fri), 09:00-10:15
• TBD
• 09:00-09:25 A Personalized Approach to Immune Therapies for Cancer: One Drug, One Patient Larry W. Kwak (City of Hope, USA) 09:25-09:50 Paradigm Shift of DLBCL Treatment Based on Bispecific Abs Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) 09:50-10:15 Paradigm shift of DLBCL Treatment Based on MRD-Driven Approach Ash A. Alizadeh (Stanford University, USA)

[ES04] Education Session 04: Understanding Anemia Supernova Stage

• March 27 (Fri), 09:00-10:15
• TBD
• 09:00-09:25 Iron Deficiency & Iron Metabolism Jeong-Ok Lee (Seoul National University College of Medicine, Korea) 09:25-09:50 Hereditary Hemolytic Anemia Heewon Chueh (Inje University Haeundae Paik Hospital, Korea) 09:50-10:15 Cold Agglutinin Disease Dae-Ho Choi (Sungkyunkwan University School of Medicine, Korea)

[PL02] Plenary Lecture 02 Galaxy Theater & Discovery Hall

• March 27 (Fri), 10:30-11:15
• TBD
• 10:30-11:15 The Present and Future of Hematopoietic Stem Cell Gene Therapies Cynthia E. Dunbar (National Institutes of Health, USA)

[SS10] Scientific Session 10: Pediatric Malignancies: From Patients to Survivors Discovery Hall

• March 27 (Fri), 15:05-16:20
• TBD
• 15:05-15:30 Menin Inhibitors and Epigenetic Therapy in KMT2A-rearranged ALL Elisabeth Salzer (St. Anna Children's Hospital, Austria) 15:30-15:55 Virus-specific and Next-generation T-cell Therapy in Pediatric Hematologic Malignancy Catherine Bollard (Children’s National Hospital, USA) 15:55-16:20 Pediatric Cancer Survivorship and Long-Term Toxicities Sharon M. Castellino (Emory University School of Medicine, USA)

[SS11] Scientific Session 11: Transforming the Therapeutic Landscape of AML: From Biology to Targeted Therapies Universe Arena

• March 27 (Fri), 15:05-16:20
• TBD
• 15:05-15:30 Leukemia Stem Cells, Clonal Evolution, and Immune Evasion in AML: Translational Insights and Therapeutic Opportunities Ravindra Majeti (Stanford University, USA) 15:30-15:55 Menin Inhibition in AML: Evolving Frontiers in Targeted Therapy Eytan M. Stein (Memorial Sloan Kettering Cancer Center, USA) 15:55-16:20 HMA + Venetoclax + Targeted Agents: Clinical Evidence and Future of Triplet Therapy in AML Tapan Kadia (The University of Texas MD Anderson Cancer Center, USA)

[ES05] Education Session 05: Big Data and AI in Hematology Research Supernova Stage

• March 27 (Fri), 15:05-16:20
• TBD
• 15:05-15:30 Real-World Effectiveness of Immunotherapy in Hematologic Malignancies: Evidence from Big Data Sung-Soo Park (College of Medicine, The Catholic University of Korea, Korea) 15:30-15:55 Digital Healthcare Innovation: Real-World Applications of Big Data and AI Yoon Sup Choi (Digital Healthcare Partners, Korea) 15:55-16:20 Wise Hematology Life: Use of AI Ki-Hyun Jeon (Seoul National University College of Medicine, Korea)

[SS12] Scientific Session 12: Expanding Therapeutic Horizons in ITP and TTP Discovery Hall

• March 27 (Fri), 16:35-17:50
• TBD
• 16:35-17:00 Real World Long Term TPO-RA: Sustaining Remission or Time to Stop? Nichola Cooper (Imperial College Healthcare NHS Trust, UK) 17:00-17:25 A New Chapter in ITP management - Updated trials Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea) 17:25-17:50 Caplacizumab and the Changing Landscape of TTP Management Shruti Chaturvedi (Johns Hopkins University School of Medicine, USA)

[SS13] Scientific Session 13: Other Plasma Cell Disorders: From Diagnosis to Mechanistic Insights Universe Arena

• March 27 (Fri), 16:35-17:50
• TBD
• 16:35-17:00 AL Amyloidosis: A Comprehensive Update from Fundamentals to Emerging Therapies Efstathios Kastritis (National and Kapodistrian University of Athens, Greece) 17:00-17:25 Monoclonal Gammopathy and the Kidney: A Comprehensive Approach to MGRS Nelson Leung (Mayo Clinic, USA) 17:25-17:50 POEMS Syndrome: From Longitudinal Clinical Experience to Translational Insights Emiko Sakaida (Chiba University Hospital, Japan)

[ES06] Education Session 06: Toxicity Masterclass: Managing CRS, Cytopenia, and Infections in T Cell Engaging Therapies Supernova Stage

• March 27 (Fri), 16:35-17:50
• TBD
• 16:35-17:00 CRS and ICANS: Early Detection and Personalized Management Jinchul Kim (Inha University College of Medicine, Korea) 17:00-17:25 Prolonged Cytopenia after TCEs: Mechanisms, Biomarkers, and Risk Stratification Sang Eun Yoon (Sungkyunkwan University School of Medicine, Korea) 17:25-17:50 Preventing Infections in TCEs: Risk Stratification and Prophylaxis Ja Min Byun (Seoul National University College of Medicine, Korea)